RARE ALERT: GlaxoSmithKline said to ... - Part 5
The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.
Date:Tuesday, 22 March 2022 4:24 pm
